CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel [Phase 3]
Summary
A Phase 3 bioequivalence trial comparing Tretinoin Gel 0.05% to the brand version in acne patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spear Pharmaceuticals | Conditions: Acne | Phase 3 | Status: COMPLETED | Results posted: 2020-01-13